gastric

Keytruda shines in phase III gastric cancer trial

Keytruda shines in phase III gastric cancer trial

Credit: luismmolina/Getty Images One of the world’s best-selling drugs, Merck’s anti-PD-1 treatment KEYTRUDA (pembrolizumal), is launching into new territories. The Company Just Released Positive Topline Results from a Phase III Trial of KEYTRUDA in Combination with Chemotherapy in Patients With Growth Factor Receptor Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma human epidermal 2 (HER2). Patients …

Keytruda shines in phase III gastric cancer trial Read More »